NeuroNexus Technologies, Inc., a neurotechnology company, develops and commercializes neural interface components and systems for neuroscience research and clinical applications. Its neural research products include microelectrode arrays, probe accessories and instrumentation, and custom-designed systems for neural recording, microstimulation, and drug delivery; and clinical products comprise electrode systems and neural interface products for diagnostic and therapeutic neurological applications. The company's proprietary microelectronic, fluidic, and optical technology is used to map brain function, detect neural activity, and stimulate or modulate neural circuits when brain function is impaired. In February 2012, NeuroNexus was acquired by Greatbatch - itself having been an SBIR Awardee earlier in life. NeuroNexus was integrated with Greatbatchâs QiG Group, created in 2008 to design, develop, and manufacture novel devices.
